当前位置:首页 - 行情中心 - 悦康药业(688658) - 财务分析

悦康药业

(688658)

  

流通市值:33.82亿  总市值:74.39亿
流通股本:2.05亿   总股本:4.50亿

悦康药业(688658)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.69亿元,每股收益0.15元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益364496.26万元,未分配利润45475.42万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产610903.74万元,负债246407.48万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入967,900,022.684,196,300,749.572,957,716,328.492,199,926,860.87
营业总成本904,066,984.173,960,329,636.782,787,559,797.211,967,382,654.11
营业利润80,364,945.02231,752,750.82172,462,554.46234,845,316.47
利润总额79,115,648.13223,268,263.96165,761,105.35229,151,335.06
净利润69,124,285.22187,494,090.53154,624,259.72208,633,261
其他综合收益----
综合收益总额69,124,285.22187,494,090.53154,624,259.72208,633,261
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计3,625,964,182.863,424,676,946.883,294,705,773.313,593,984,850.79
非流动资产合计2,483,073,207.262,486,599,454.922,418,644,964.872,306,764,587.45
资产总计6,109,037,390.125,911,276,401.85,713,350,738.185,900,749,438.24
流动负债合计2,035,140,002.432,136,632,435.561,954,705,573.442,121,924,618.37
非流动负债合计428,934,780.76177,004,400.11152,392,903.41105,058,365.11
负债合计2,464,074,783.192,313,636,835.672,107,098,476.852,226,982,983.48
归属于母公司股东权益合计3,635,346,891.713,587,842,712.33,596,804,267.173,665,111,147.37
股东权益合计3,644,962,606.933,597,639,566.133,606,252,261.333,673,766,454.76
负债和股东权益合计6,109,037,390.125,911,276,401.85,713,350,738.185,900,749,438.24
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计1,099,895,626.674,876,328,058.643,679,239,176.012,597,872,039.38
经营活动现金流出小计953,764,729.44,090,836,476.13,183,344,949.452,110,641,605.87
经营活动产生的现金流量净额146,130,897.27785,491,582.54495,894,226.56487,230,433.51
投资活动现金流入小计124,802.0510,930,936.1410,351,989.256,724,255.25
投资活动现金流出小计90,961,646.48512,977,682.58427,881,073272,109,438.02
投资活动产生的现金流量净额-90,836,844.43-502,046,746.44-417,529,083.75-265,385,182.77
筹资活动现金流入小计281,730,725387,292,022346,555,000202,000,000
筹资活动现金流出小计92,464,155.54819,484,069.68687,820,608.42558,999,060.15
筹资活动产生的现金流量净额189,266,569.46-432,192,047.68-341,265,608.42-356,999,060.15
汇率变动对现金及现金等价物的影响120,751.253,935,520.173,871,677.523,559,659.29
现金及现金等价物净增加额244,681,373.55-144,811,691.41-259,028,788.09-131,594,150.12
期末现金及现金等价物余额1,618,214,563.841,373,533,190.291,259,316,093.611,386,750,731.58
最新报告期:2024-05-02
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
开源证券余汝意0.710.911.222024-05-02
东吴证券朱国广0.760.99--2024-02-08
TOP↑